The 'therapeutic window' and treating to target in rheumatoid arthritis.
作者信息
Hunt Laura, Buch Maya
机构信息
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
出版信息
Clin Med (Lond). 2013 Aug;13(4):387-90. doi: 10.7861/clinmedicine.13-4-387.
Abstract
摘要
相似文献
1
The 'therapeutic window' and treating to target in rheumatoid arthritis.类风湿关节炎中的“治疗窗”与达标治疗
Clin Med (Lond). 2013 Aug;13(4):387-90. doi: 10.7861/clinmedicine.13-4-387.
2
Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.定义类风湿关节炎患者对改善病情抗风湿药物的反应。
J Rheumatol. 2005 Jan;32(1):6-10.
3
Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.影响类风湿关节炎患者对改善病情抗风湿药物反应的因素。
J Rheumatol. 2005 Jan;32(1):11-16.
4
The merits of monitoring: should we follow all our rheumatoid arthritis patients in daily practice?监测的益处：在日常实践中我们是否应该对所有类风湿关节炎患者进行随访？
Rheumatology (Oxford). 2002 Jun;41(6):601-4. doi: 10.1093/rheumatology/41.6.601.
5
Leflunomide in Pakistani patients with rheumatoid arthritis: prospective study in daily rheumatology practice.来氟米特治疗巴基斯坦类风湿关节炎患者：日常风湿病实践中的前瞻性研究。
Int J Rheum Dis. 2011 Feb;14(1):48-54. doi: 10.1111/j.1756-185X.2010.01586.x.
6
Advances in use of immunomodulatory agents--a rheumatology perspective.免疫调节剂的应用进展——风湿病学视角。
Nat Rev Gastroenterol Hepatol. 2015 Jun;12(6):363-8. doi: 10.1038/nrgastro.2015.65. Epub 2015 Apr 21.
7
Therapeutic strategies in early rheumatoid arthritis.早期类风湿性关节炎的治疗策略
Best Pract Res Clin Rheumatol. 2005 Feb;19(1):163-77. doi: 10.1016/j.berh.2004.08.009.
8
What lies in the near future for the treatment of rheumatoid arthritis?类风湿关节炎的治疗在不久的将来会怎样？
Reumatol Clin. 2017 Sep-Oct;13(5):249-251. doi: 10.1016/j.reuma.2017.04.001. Epub 2017 May 9.
9
Rheumatoid arthritis: principles of early treatment.类风湿关节炎：早期治疗原则
J Rheumatol Suppl. 2002 Nov;66:9-12.
10
Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms.类风湿关节炎中治疗性B细胞清除与再生：新出现的模式与范例
Arthritis Rheum. 2006 Aug;54(8):2356-67. doi: 10.1002/art.22020.
引用本文的文献
1
Cucurbitacin B inhibits Th17 cell differentiation via the suppression of the JAK/STAT pathway and alleviates collagen-induced arthritis in mice.葫芦素B通过抑制JAK/STAT信号通路抑制Th17细胞分化，并减轻小鼠胶原诱导的关节炎。
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251348715. doi: 10.1177/03946320251348715. Epub 2025 Jun 16.
2
An AI Approach to Identifying Novel Therapeutics for Rheumatoid Arthritis.一种用于识别类风湿关节炎新型疗法的人工智能方法。
J Pers Med. 2023 Nov 23;13(12):1633. doi: 10.3390/jpm13121633.
3
Time-Varying Association of Rheumatoid Arthritis Disease Activity to Subsequent Cardiovascular Risk.类风湿关节炎疾病活动与后续心血管风险的时变关联。
ACR Open Rheumatol. 2022 Jul;4(7):587-595. doi: 10.1002/acr2.11432. Epub 2022 Apr 10.
本文引用的文献
1
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.小剂量泼尼松加入甲氨蝶呤为基础的紧密控制策略治疗早期类风湿关节炎：一项随机试验。
Ann Intern Med. 2012 Mar 6;156(5):329-39. doi: 10.7326/0003-4819-156-5-201203060-00004.
2
The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.贝达喹啉治疗耐多药肺结核的研究（Bedaquiline in Multidrug-Resistant Tuberculosis）
Ann Rheum Dis. 2011 Jun;70(6):1039-46. doi: 10.1136/ard.2010.141234. Epub 2011 Mar 17.
3
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.2010年类风湿关节炎分类标准：美国风湿病学会/欧洲抗风湿病联盟合作项目
Arthritis Rheum. 2010 Sep;62(9):2569-81. doi: 10.1002/art.27584.
4
Long-term impact of delay in assessment of patients with early arthritis.早期关节炎患者评估延迟的长期影响。
Arthritis Rheum. 2010 Dec;62(12):3537-46. doi: 10.1002/art.27692.
5
Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.早期联合疾病修饰抗风湿药物治疗和严格疾病控制可改善早期类风湿关节炎患者的长期放射学结局：芬兰类风湿关节炎联合治疗试验的 11 年结果。
Arthritis Res Ther. 2010;12(3):R122. doi: 10.1186/ar3060. Epub 2010 Jun 24.
6
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.EULAR 推荐的使用合成和生物疾病修饰抗风湿药物治疗类风湿关节炎的建议。
Ann Rheum Dis. 2010 Jun;69(6):964-75. doi: 10.1136/ard.2009.126532. Epub 2010 May 5.
7
Treating rheumatoid arthritis to target: recommendations of an international task force.靶向治疗类风湿关节炎：国际工作组的建议。
Ann Rheum Dis. 2010 Apr;69(4):631-7. doi: 10.1136/ard.2009.123919. Epub 2010 Mar 9.
8
Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis.根据病程，美国风湿病学会1987年类风湿关节炎诊断标准的敏感性和特异性：一项系统文献综述和荟萃分析
Ann Rheum Dis. 2009 Jul;68(7):1184-91. doi: 10.1136/ard.2008.093187. Epub 2008 Aug 26.
9
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.甲氨蝶呤单药疗法与甲氨蝶呤和依那西普联合疗法治疗活动期、早期、中重度类风湿关节炎的比较（COMET）：一项随机、双盲、平行治疗试验
Lancet. 2008 Aug 2;372(9636):375-82. doi: 10.1016/S0140-6736(08)61000-4. Epub 2008 Jul 16.
10
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.类风湿关节炎患者采用甲氨蝶呤单药治疗以及英夫利昔单抗联合甲氨蝶呤治疗并达到不同疾病活动状态时的影像学改变：缓解和肿瘤坏死因子阻断的影响
Ann Rheum Dis. 2009 Jun;68(6):823-7. doi: 10.1136/ard.2008.090019. Epub 2008 Jul 1.
Zotero 插件